ETF Holdings Breakdown of ABBV

Stock Name	AbbVie Inc
Ticker	ABBV(USD) NYSE
TYPE	Common Stock
Country	USA
ISIN	US00287Y1091
LEI	FR5LCKFTG8054YNNRU85

ABBV institutional holdings

The adjusted close for ABBV on 2026-01-23 was 219.26

The following institutional investment holdings of ABBV have been identified

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share
2026-01-23	IE00019GPKX6 (iShares MSCI ACWI UCITS ETF SGD Hedged (Acc))	493,782	USD 108,266,641 1.4%	219.26
2026-01-23	IE0001YGXFO5 (iShares MSCI World Climate Transition Aware UCITS ETF USD (Acc))	266	USD 58,323 0.5%	219.26
2026-01-23	IE0003WV2ME7 (iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc))	39,852 1.0%	USD 8,737,950 1.5%	219.26
2026-01-23	IE0009QS7W62 (iShares MSCI World Health Care Sector ESG UCITS ETF USD (Acc))	172,373	USD 37,794,504 0.5%	219.26
2026-01-23	IE0009VWHAE6 (iShares US Equity Enhanced Active UCITS ETF USD (Acc))	35,914	USD 7,874,504 0.5%	219.26
2026-01-23	IE000D3BWBR2 (iShares S&P 500 Swap UCITS ETF USD (Dist))	46,735 200.0%	USD 10,247,116 199.5%	219.26
2026-01-23	IE000D8XC064 (iShares World Equity Enhanced Active UCITS ETF USD (Acc))	35,232 -0.7%	USD 7,724,968 -0.2%	219.26
2026-01-23	IE000G2LIHG9 (iShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc))	585,561 -0.1%	USD 128,390,105 1.3%	219.26
2026-01-23	IE000G4PH2B1 (iShares S&P 500 Paris-Aligned Climate UCITS ETF USD Dist)	51,216 0.9%	USD 11,229,620 1.4%	219.26
2026-01-23	IE000KJPDY61 (iShares World Equity High Income UCITS ETF USD Inc)	5,108 92.9%	USD 1,119,980 92.9%	219.26
2026-01-23	IE000MGAVJV3 (iShares MSCI USA Climate Transition Aware UCITS ETF USD (Acc))	259	USD 56,788 0.5%	219.26
2026-01-23	IE000MLMNYS0 (iShares S&P 500 Equal Weight UCITS ETF USD (Acc))	39,852 1.0%	USD 8,737,950 1.5%	219.26
2026-01-23	IE000NITTFF2 (iShares Russell 1000 Growth UCITS ETF)	38,340 -0.6%	USD 8,406,428 -0.1%	219.26
2026-01-23	IE000OHHIBC6 (iShares Core MSCI World UCITS ETF USD (Dist))	2,792,875	USD 612,365,773 0.5%	219.26
2026-01-23	IE000R9FA4A0 (iShares S&P 500 ESG UCITS ETF USD (Acc))	36,553	USD 8,014,611 0.5%	219.26
2026-01-23	IE000WHL2ZK1 (iShares U.S. Equity High Income UCITS ETF USD Inc)	1,213	USD 265,962 0.5%	219.26
2026-01-23	IE000YG82CF0 (iShares MSCI USA Climate Transition Aware UCITS ETF USD (Dist))	259	USD 56,788 0.5%	219.26
2026-01-23	IE000YNE6S57 (iShares MSCI World Climate Transition Aware UCITS ETF USD (Dist))	266	USD 58,323 0.5%	219.26
2026-01-23	IE0031442068 (iShares Core S&P 500 UCITS ETF USD (Dist))	610,949 0.0%	USD 133,956,678 0.5%	219.26
2026-01-23	IE00B0M62Q58 (iShares MSCI World UCITS ETF USD (Dist))	183,160	USD 40,159,662 0.5%	219.26
2026-01-23	IE00B14X4M10 (iShares MSCI North America UCITS ETF USD (Dist) USD)	35,987	USD 7,890,510 0.5%	219.26
2026-01-23	IE00B3Y8X563 (iShares S&P 500 GBP Hedged UCITS ETF (Acc))	43,642	USD 7,054,663 -0.1%	161.65 Incorrect share price reported. Should be 219.26 not 161.65. May be due to incorrect reporting of currency . Could be EUR or USD instead
2026-01-23	IE00B3ZW0K18 (iShares S&P 500 EUR Hedged UCITS ETF (Acc))	279,075	USD 52,043,363 0.3%	186.49 Incorrect share price reported. Should be 219.26 not 186.49. May be due to incorrect reporting of currency . Could be EUR or USD instead
2026-01-23	IE00B42YS929 (iShares MSCI World GBP Hedged UCITS ETF (Acc))	11,611	USD 1,876,901 -0.1%	161.65 Incorrect share price reported. Should be 219.26 not 161.65. May be due to incorrect reporting of currency . Could be EUR or USD instead
2026-01-23	IE00B43HR379 (iShares S&P 500 Health Care Sector UCITS ETF USD (Acc))	906,700 0.1%	USD 198,803,042 0.6%	219.26
2026-01-23	IE00B441G979 (iShares MSCI World EUR Hedged UCITS ETF (Acc))	118,764	USD 22,147,731 1.0%	186.49 Incorrect share price reported. Should be 219.26 not 186.49. May be due to incorrect reporting of currency . Could be EUR or USD instead
2026-01-23	IE00B4L5Y983 (iShares Core MSCI World UCITS ETF USD (Acc))	2,792,875	USD 612,365,773 0.5%	219.26
2026-01-23	IE00B57X3V84 (iShares Dow Jones Global Sustainability Screened UCITS ETF USD (Acc))	154,635	USD 33,905,270 0.5%	219.26
2026-01-23	IE00B5BMR087 (iShares Core S&P 500 UCITS ETF USD (Acc))	4,155,915 0.1%	USD 911,225,923 0.6%	219.26
2026-01-23	IE00B6R52259 (iShares MSCI ACWI UCITS ETF)	493,782	USD 108,266,641 1.4%	219.26
2026-01-23	IE00B6SPMN59 (iShares Edge S&P 500 Minimum Volatility UCITS ETF USD (Acc))	145,504 -0.4%	USD 31,903,207 0.1%	219.26
2026-01-23	IE00B8FHGS14 (iShares Edge MSCI World Minimum Volatility UCITS ETF USD (Acc))	68,652 -2.3%	USD 15,052,638 -1.7%	219.26
2026-01-23	IE00BD45YS76 (iShares Core MSCI World UCITS ETF GBP Hedged (Dist))	2,792,875	USD 612,365,773 0.5%	219.26
2026-01-23	IE00BD8KRH84 (iShares Core S&P 500 UCITS ETF GBP Hedged (Dist))	4,155,915 0.1%	USD 911,225,923 0.6%	219.26
2026-01-23	IE00BD93YH54 (iShares Edge S&P 500 Minimum Volatility UCITS ETF USD (Dist))	145,504 -0.4%	USD 31,903,207 0.1%	219.26
2026-01-23	IE00BFNM3G45 (iShares MSCI USA ESG Screened UCITS ETF USD (Acc))	585,561 -0.1%	USD 128,390,105 0.4%	219.26
2026-01-23	IE00BFNM3H51 (iShares MSCI USA ESG Screened UCITS ETF USD (Dist))	585,561 -0.1%	USD 128,390,105 0.4%	219.26
2026-01-23	IE00BFNM3J75 (iShares MSCI World ESG Screened UCITS ETF)	159,550 0.9%	USD 34,982,933 1.4%	219.26
2026-01-23	IE00BFNM3K80 (iShares MSCI World ESG Screened UCITS ETF USD (Dist))	159,550 0.9%	USD 34,982,933 1.4%	219.26
2026-01-23	IE00BG11HV38 (iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP)	156,207	USD 34,249,947 0.5%	219.26
2026-01-23	IE00BG13YZ23 (iShares Edge MSCI USA Multifactor UCITS ETF USD (Dist))	5,820 8.8%	USD 1,276,093 9.3%	219.26
2026-01-23	IE00BGPP8L80 (iShares Edge MSCI World Minimum Volatility UCITS ETF GBP Hedged (Acc))	68,652 -2.3%	USD 15,052,638 -1.7%	219.26
2026-01-23	IE00BHZPJ569 (iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP)	156,207	USD 34,249,947 0.5%	219.26
2026-01-23	IE00BHZPJ890 (iShares MSCI USA ESG Enhanced UCITS ETF USD (Dist))	787,899	USD 172,754,735 0.5%	219.26
2026-01-23	IE00BJ5JNZ06 (iShares MSCI World Health Care Sector ESG UCITS ETF)	172,373	USD 37,794,504 0.5%	219.26
2026-01-23	IE00BKBF6H24 (iShares Core MSCI World UCITS ETF)	2,792,875	USD 612,365,773 0.5%	219.26
2026-01-23	IE00BKM4H312 (iShares MSCI USA Dividend IQ UCITS)	73,066	USD 16,020,451 0.5%	219.26
2026-01-23	IE00BKVL7331 (iShares Edge MSCI USA Minimum Volatility ESG UCITS ETF USD (Acc))	858	USD 188,125 0.5%	219.26
2026-01-23	IE00BL3J3G74 (iShares Core S&P 500 UCITS ETF MXN Hedged (Acc))	4,155,915 0.1%	USD 911,225,923 0.6%	219.26
2026-01-23	IE00BMBKBZ46 (iShares S&P 500 Health Care Sector UCITS ETF)	906,700 0.1%	USD 198,803,042 0.6%	219.26
2026-01-23	IE00BMTX1Y45 (iShares S&P 500 Swap UCITS ETF USD (Acc))	46,735 200.0%	USD 10,247,116 199.5%	219.26
2026-01-23	IE00BMXC7V63 (iShares S&P 500 Paris-Aligned Climate UCITS ETF USD (Acc))	51,216 0.9%	USD 11,229,620 1.4%	219.26
2026-01-23	IE00BMXC7W70 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Acc))	10,267	USD 2,251,142 0.5%	219.26
2026-01-23	IE00BN92ZL31 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Dist))	10,267	USD 2,251,142 0.5%	219.26
2026-01-23	IE00BYXPXK00 (iShares STOXX World Equity Multifactor UCITS ETF EUR Hedged (Acc))	37,553	USD 8,233,871 0.5%	219.26
2026-01-23	IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc))	80,224 0.4%	USD 17,589,914 0.9%	219.26
2026-01-23	IE00BZ0PKS76 (iShares STOXX USA Equity Multifactor UCITS ETF USD (Acc))	5,820 8.8%	USD 1,276,093 9.3%	219.26
2026-01-23	IE00BZ0PKT83 (iShares Edge MSCI World Multifactor UCITS ETF USD (Acc) GBP)	37,553	USD 8,233,871 0.5%	219.26
2026-01-22	IE00B52SFT06 (iShares MSCI USA UCITS ETF USD (Acc))	99,571	USD 21,717,431 0.9%	218.11 Incorrect share price reported. Should be 219.26 not 218.11. May be due to incorrect reporting of currency . Could be EUR or USD instead
Total =	32,617,201	USD 7,135,310,693

News associated with ABBV

AbbVie (NYSE:ABBV) Reaches New 12-Month High After Analyst Upgrade: AbbVie Inc. (NYSE:ABBV – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Thursday after Berenberg Bank upgraded the stock from a hold rating to a buy rating. Berenberg Bank now has a $270.00 price target on the stock, up from their previous price target of $170.00. AbbVie traded as […] - 2025-09-19 03:10:53
AbbVie (NYSE:ABBV) Upgraded by Berenberg Bank to Buy Rating: AbbVie (NYSE:ABBV – Get Free Report) was upgraded by investment analysts at Berenberg Bank from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday, Marketbeat reports. The firm currently has a $270.00 price target on the stock, up from their previous price target of $170.00. Berenberg […] - 2025-09-19 02:24:45
Noteworthy Thursday Option Activity: ZS, CRM, ABBV: Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Zscaler Inc (Symbol: ZS), where a total of 10,858 contracts have traded so far, representing approximately 1.1 million underlying shares. That amounts to about 58.1% of - 2025-09-18 16:21:04
Notable ETF Inflow Detected - ITOT, HD, ABBV, AMD: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core S&P Total U.S. Stock Market ETF (Symbol: ITOT) where we have detected an approximate $179.9 million dollar inflow -- that's a 0.2% i - 2025-09-18 13:25:16
Guru Fundamental Report for ABBV: Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our Multi-Factor Investor model based on the published strategy of Pim van Vliet. This multi-factor model seeks low volatility stocks that also have st - 2025-09-18 10:39:12
AbbVie (NYSE:ABBV) Trading Up 1.8% on Analyst Upgrade: AbbVie Inc. (NYSE:ABBV – Get Free Report) shares rose 1.8% on Wednesday after Berenberg Bank upgraded the stock from a hold rating to a buy rating. Berenberg Bank now has a $270.00 price target on the stock, up from their previous price target of $170.00. AbbVie traded as high as $221.55 and last traded at […] - 2025-09-18 03:08:42
ABBV Factor-Based Stock Analysis: Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-09-17 10:34:46
AbbVie (NYSE:ABBV) Price Target Raised to $245.00: AbbVie (NYSE:ABBV – Get Free Report) had its target price boosted by equities researchers at Cantor Fitzgerald from $215.00 to $245.00 in a research note issued to investors on Monday, MarketBeat reports. The brokerage currently has an “overweight” rating on the stock. Cantor Fitzgerald’s price objective points to a potential upside of 13.28% from the […] - 2025-09-17 02:56:46
ABBV Quantitative Stock Analysis: Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-09-16 10:32:29
Validea Detailed Fundamental Analysis - ABBV: Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-09-12 10:32:52
Company News for Sep 12, 2025: Companies in The News Are: TSLA, WBD, DOW, ABBV - 2025-09-12 10:18:00
The Best Stocks to Invest $50,000 In Right Now: Key PointsAbbVie is a Dividend King that's proven its resilience. - 2025-09-12 05:46:00
Notable Thursday Option Activity: ABBV, LRCX, UAL: Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in AbbVie Inc (Symbol: ABBV), where a total volume of 26,476 contracts has been traded thus far today, a contract volume which is representative of approximately 2.6 - 2025-09-11 14:43:20
Noteworthy ETF Inflows: VONG, ABBV, HD, RCL: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Russell 1000 Growth ETF (Symbol: VONG) where we have detected an approximate $454.7 million dollar inflow -- that's a 1.4% increase week ove - 2025-09-10 11:51:17
ABBV Factor-Based Stock Analysis: Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-09-10 10:34:13
Daily Dividend Report: VZ,ESS,AVGO,SACH,ABBV,NUE: The Board of Directors at Verizon Communications today declared a quarterly dividend of 69 cents per outstanding share, an increase of 1.25 cents per share from the previous quarter. The quarterly dividend is payable on November 3, 2025 to Verizon shareholders of record at the c - 2025-09-05 12:59:15
Guru Fundamental Report for ABBV: Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-09-04 10:32:24
Validea Detailed Fundamental Analysis - ABBV: Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-29 10:33:22
ABBV Factor-Based Stock Analysis: Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-27 10:34:48
ABBV Quantitative Stock Analysis: Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-26 10:34:00
Noteworthy ETF Inflows: SSO, ABBV, BAC, KO: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares Ultra S&P500 (Symbol: SSO) where we have detected an approximate $147.7 million dollar inflow -- that's a 2.1% increase week over week - 2025-08-25 13:36:49
Validea Detailed Fundamental Analysis - ABBV: Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-22 10:34:21
ABBV Factor-Based Stock Analysis: Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-20 10:33:59
Noteworthy ETF Outflows: ACWI, ABBV, BAC, KO: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI ACWI ETF (Symbol: ACWI) where we have detected an approximate $160.0 million dollar outflow -- that's a 0.7% decrease week over week (f - 2025-08-15 11:48:20
Validea Detailed Fundamental Analysis - ABBV: Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-15 10:31:59
3 Dividend Stocks to Double Up On Right Now: Key PointsAbbVie is a Dividend King with an especially attractive valuation. - 2025-08-15 05:53:00
ABBV Quantitative Stock Analysis: Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-12 10:33:16
Guru Fundamental Report for ABBV: Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-07 10:34:43
AbbVie (NYSE:ABBV) Price Target Raised to $255.00: AbbVie (NYSE:ABBV – Free Report) had its target price boosted by Morgan Stanley from $250.00 to $255.00 in a research report released on Friday,Benzinga reports. Morgan Stanley currently has an overweight rating on the stock. A number of other analysts have also recently issued reports on the company. Cantor Fitzgerald assumed coverage on AbbVie in […] - 2025-08-04 04:57:06
AbbVie (NYSE:ABBV) Price Target Raised to $227.00: AbbVie (NYSE:ABBV – Free Report) had its target price boosted by Guggenheim from $216.00 to $227.00 in a report published on Friday morning,Benzinga reports. They currently have a buy rating on the stock. ABBV has been the subject of a number of other research reports. Citigroup boosted their target price on shares of AbbVie to […] - 2025-08-04 04:56:58

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.